Welcome to our dedicated page for Standex Intl SEC filings (Ticker: SXI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Standex International Corporation filings document the reporting obligations of a diversified industrial manufacturer with operations across Electronics, Engineering Technologies, Scientific, Engraving, and Specialty Solutions. Form 8-K filings furnish quarterly results, segment performance commentary, order trends, portfolio actions, leverage updates, and exhibits tied to earnings releases.
The company’s proxy and governance filings cover director elections, advisory executive compensation votes, auditor ratification, board matters, and executive compensation disclosures. Other current reports record officer transitions and related management changes, providing formal disclosure on governance, leadership structure, financial reporting, and capital-allocation matters.
SXI filed a Form 144 indicating a proposed sale of up to 1,823 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of 11/04/2025 and an aggregate market value of $419,560.24.
The shares to be sold were acquired on 08/23/2025 via restricted stock vesting as compensation. Shares outstanding were 12,116,999.
Recent insider activity disclosed in the notice shows sales by Ademir Sarcevic over the past three months: 3,047 shares on 08/06/2025 for $584,446.61 and 1,085 shares on 08/26/2025 for $227,739.90. A Form 144 is a notice of potential sales by affiliates and does not obligate a sale to occur.
Standex International (SXI) reported an initial insider ownership filing. The company’s Chief Strategy Officer filed a Form 3 effective 10/27/2025, disclosing 5,697 shares of common stock, which includes 118 restricted shares subject to vesting.
The filing also lists derivative awards: phantom stock units tied to common stock of 161, 246, 352, 436, and 483 shares, and restricted stock units of 291 and 483 shares. Footnotes state phantom units vest after three years under the Management Stock Purchase Plan, performance share units cliff vest after a three‑year period subject to metrics, and RSUs vest one‑third annually.
Standex International Corporation reported the results of its Annual Meeting of Stockholders. Shareholders elected two directors to three-year terms ending at the 2028 annual meeting: Thomas E. Chorman (For: 9,623,949; Against: 1,253,659; Abstain: 1,454) and Andy L. Nemeth (For: 10,859,557; Against: 17,250; Abstain: 2,255).
Stockholders approved the advisory vote on executive compensation with 10,660,832 votes For, 213,117 Against, and 5,113 Abstain. They also ratified Deloitte & Touche LLP as the Company’s independent public accountants for the fiscal year ending June 30, 2026, with 10,943,594 votes For, 359,021 Against, and 1,619 Abstain. A total of 11,304,234 common shares were represented at the meeting.
Standex International (SXI) reported Q1 FY2026 results for the three months ended September 30, 2025. Net sales were $217.4 million, up from $170.5 million, led by Electronics at $110.6 million and Engraving at $35.8 million. Diluted EPS was $1.25 versus $1.53 a year ago as expenses increased.
Operating income was $29.6 million and included $6.0 million of restructuring costs and $0.4 million of acquisition costs. Interest expense rose to $8.9 million from $1.0 million, reducing income from continuing operations to $15.8 million. Cash from operations was $16.8 million. Cash and equivalents were $98.7 million, and long‑term debt was $544.6 million.
The company advanced integration of recent deals: McStarlite (cash consideration $57.0 million net of cash acquired) and the Amran/Narayan Group (final allocation: identifiable intangibles $136.0 million, goodwill $298.4 million). An interest rate swap effective August 30, 2025 fixes $225 million of borrowings at 3.48% through August 30, 2028. A quarterly dividend of $0.32 per share was declared.
Standex International Corporation (SXI) filed an 8-K to furnish its earnings press release for the first quarter ended September 30, 2025. The press release is provided as Exhibit 99 and is incorporated by reference. The filing uses Item 2.02 (Results of Operations and Financial Condition) and also includes the Exhibit 104 Cover Page Inline XBRL file.
The company notes that the communication contains forward-looking statements subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, with risk factors referenced in the accompanying release and the company’s Form 10-K for the fiscal year ended June 30, 2025.
Standex International (SXI) reported an insider transaction by its VP, Chief HR Officer. A Form 4 shows 111 shares of common stock were forfeited at $244.87 on 10/24/2025 to cover taxes tied to the vesting of previously issued restricted stock. Following the transaction, the officer directly owned 7,311 shares.
Standex International Corporation (SXI) reported a routine insider equity grant. A director acquired 639 shares of Common Stock on 10/21/2025 at a stated price of $0, reflecting a restricted stock award under the company’s 2018 Omnibus Incentive Plan.
The award vests three years after the date of grant. Following this transaction, the reporting person’s beneficial ownership stands at 14,229 shares, held directly.
Standex International (SXI): A company director reported a grant of 639 restricted shares of common stock on 10/21/2025 at $0 under the company’s 2018 Omnibus Incentive Plan. The award is scheduled to vest three years after the grant date.
Following this transaction, the director’s beneficial ownership stands at 12,905.4464 shares, held directly. This filing records an equity compensation award and does not indicate any open‑market purchase or sale.
Standex International (SXI) reported an insider equity award. Director Alan J. Glass acquired 639 shares of common stock on 10/21/2025 via a restricted stock grant under the Company’s 2018 Omnibus Incentive Plan. The award carries a $0 price, reflecting a grant rather than an open‑market purchase, and vests three years after the date of grant.
Following this transaction, the reporting person beneficially owned 14,424 shares, held directly.
Standex International (SXI) reported an insider equity award. A company director acquired 639 shares of Common Stock on 10/21/2025 at $0 via a restricted stock grant under the 2018 Incentive Plan.
The award vests three years after the date of grant. After this transaction, the director beneficially owns 4,698.089 shares, held directly.